Recently, DLBCL subtypes have been characterised by NF-κB gene expression signatures, suggesting the significance of activation of this transcription factor in DLBCL pathogenesis (Rosenwald and Staudt, 2003). Here, NFKB1 is linked to diffuse large B-cell lymphoma.